Black Diamond Therapeutics Statistics
NASDAQ: BDTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.31-0.08 (-5.76%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Black Diamond Therapeutics by the numbers
Black Diamond Therapeutics has a market capitalization of $75.3 million based on 57.47M shares outstanding. With trailing EPS of $-0.77, Black Diamond Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 26.8% below its 50-day average and 38.3% below its 200-day average.
Average daily trading volume is 697.70K shares, or about $913,987 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BDTX valuation vs. peer median
| Metric | BDTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $75.28M | $64.91M | +16% |
| Avg. volume | 697.70K | 1.35M | -48% |
Peer median across 8 companies: CRDF, TNYA, ATRA, NMRA, ZURA, CSBR, LENZ, CHRS.
Valuation
- Market cap
- $75.28M
- Price / sales (latest FY)
- 1.08
- EPS (TTM)
- $-0.77
- Shares outstanding
- 57.47M
Price and trading
- Previous close
- 1.39
- Open
- 1.33
- Day range
- 1.31 – 1.41
- 52-week range
- 1.31 – 3.97
- 52-week change
- -65.53%
- Beta
- —
- Volume
- 663.19K
- Average volume
- 697.70K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 75.28M
- Forward Pe
- -1.32
- Eps
- -0.77
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.97
- Week52 Low
- 1.31
- Avg Volume
- 697.70K
- Shares Outstanding
- 57.47M
- Ma50
- 1.79
- Ma200
- 2.12
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -67.00%
- Pct From52w Low
- 0.00%